세계의 종합적 대사 패널(CMP) 검사 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 분석 항목별, 질환별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Comprehensive Metabolic Panel Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Analytes, By Disease, By End Use (Laboratory, PoC, PoC ), By Region and Competition, 2020-2030F
상품코드:1728151
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 184 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 종합적 대사 패널(CMP) 검사 시장은 2024년에 124억 1,000만 달러로 평가되었고, 2030년에는 215억 6,000만 달러에 도달할 것으로 예측되며, 예측 기간 동안 CAGR 9.62%로 성장할 전망입니다.
CMP 검사는 혈당, 간 효소, 신장 기능 및 전해질 균형을 분석하여 전반적인 대사 건강을 평가하는 데 사용되는 기본적인 진단 도구입니다. 대사성 및 만성 질환의 부담 증가와 예방적 건강 관리 및 조기 진단에 대한 전 세계적인 강조가 시장 수요를 촉진하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
124억 1,000만 달러
시장 규모(2030년)
215억 6,000만 달러
CAGR(2025-2030년)
9.62%
급성장 부문
당뇨병
최대 시장
북미
전 세계적으로 의료 시스템에서 일상적인 건강 검진을 점점 더 많이 채택함에 따라 병원, 진단 실험실 및 외래 환자 시설 전반의 표준 진단 워크플로우에 CMP 검사가 통합되고 있습니다. 이 시장은 자동화된 검사실 시스템과 현장 검사 기기의 기술 발전으로 더 빠른 처리와 폭넓은 접근성이 가능해지면서 더욱 성장하고 있습니다. 고령화 인구가 증가하고 환자 모니터링에 대한 요구가 증가함에 따라 특히 만성 질환 관리 분야에서 CMP 검사에 대한 수요가 계속 증가하고 있습니다. EHR 및 AI 기반 도구와 같은 디지털 기술의 통합은 결과 해석을 개선하여 보다 개인화된 치료에 기여하고 있습니다. 장비 비용과 소외 지역의 제한된 접근성 등의 장벽에도 불구하고 지속적인 의료 혁신과 인식 상승으로 인해 시장 전망은 여전히 강세를 보이고 있습니다.
주요 시장 성장 촉진요인
만성 및 대사성 질환의 유병률 증가
주요 시장 과제
고급 진단 장비의 높은 비용
주요 시장 동향
개인 맞춤형 및 예방적 의료 서비스로의 전환
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 종합적 대사 패널(CMP) 검사 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
분석 항목별(K+, Na+, Cl-, CO2, 포도당, BUN, 크레아티닌, Ca++, 알부민, 총 단백질, ALP, ALT, AST, 총 빌리루빈)
질환별(신장, 간, 당뇨, 기타)
최종 용도별(연구실, PoC, PoC(기기))
기업별(2024년)
지역별
시장 맵
제6장 북미의 종합적 대사 패널(CMP) 검사 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 종합적 대사 패널(CMP) 검사 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 종합적 대사 패널(CMP) 검사 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 종합적 대사 패널(CMP) 검사 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 종합적 대사 패널(CMP) 검사 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Abbott Laboratories
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings Limited
Sonic Healthcare Limited
Unipath Specialty Laboratory Limited
SYNLAB International GmbH
ARUP Laboratories
Genoptix, Inc.
Nova Medical, Inc.
Mindray Medical International Limited
제15장 전략적 제안
제16장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global Comprehensive Metabolic Panel (CMP) Testing Market was valued at USD 12.41 Billion in 2024 and is projected to reach USD 21.56 Billion by 2030, expanding at a CAGR of 9.62% during the forecast period. CMP testing is a fundamental diagnostic tool used to assess overall metabolic health by analyzing blood glucose, liver enzymes, kidney function, and electrolyte balance. The rising burden of metabolic and chronic diseases, along with the global emphasis on preventive healthcare and early diagnosis, is propelling market demand.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 12.41 Billion
Market Size 2030
USD 21.56 Billion
CAGR 2025-2030
9.62%
Fastest Growing Segment
Diabetes
Largest Market
North America
As healthcare systems worldwide increasingly adopt routine wellness screenings, CMP tests are being integrated into standard diagnostic workflows across hospitals, diagnostic labs, and outpatient facilities. The market is further supported by technological advancements in automated laboratory systems and point-of-care devices, enabling faster turnaround and broader accessibility. With the growing aging population and increased patient monitoring needs, demand for CMP testing continues to rise, especially in chronic disease management. Integration of digital technologies like EHRs and AI-based tools is enhancing result interpretation, contributing to more personalized care. Despite barriers such as equipment cost and limited access in underserved areas, the market outlook remains strong due to continuous healthcare innovations and rising awareness.
Key Market Drivers
Rising Prevalence of Chronic and Metabolic Disorders
The increasing global incidence of chronic and metabolic diseases is a major factor driving the demand for comprehensive metabolic panel testing. Noncommunicable diseases (NCDs), including cardiovascular conditions, cancers, chronic respiratory diseases, and diabetes, account for a substantial proportion of global mortality, with metabolic dysfunctions such as hyperglycemia, hypertension, and hyperlipidemia being core risk factors.
CMP tests are critical in detecting these underlying abnormalities by evaluating key biomarkers such as glucose, electrolytes, and liver and kidney function. A global analysis indicates that metabolic syndrome affects between 12.5% and 31.4% of the population, with higher rates in regions like the Eastern Mediterranean and the Americas. As early detection becomes integral to disease prevention and long-term health management, the role of CMP testing is expanding in both clinical and primary care settings, driving market growth.
Key Market Challenges
High Cost of Advanced Diagnostic Equipment
The cost associated with procuring and maintaining advanced laboratory analyzers for CMP testing presents a significant challenge, especially for small and mid-sized healthcare providers. High initial capital requirements, coupled with recurring costs for consumables, reagents, and equipment servicing, can limit market penetration in low-resource settings.
In developing regions, many diagnostic facilities lack the financial capacity to upgrade to modern systems capable of performing high-throughput and precise metabolic panel analysis. This disparity in access contributes to inconsistencies in diagnostic availability, delaying early detection and routine monitoring in underserved areas. Addressing cost-related barriers through affordable technology solutions and policy-level interventions remains vital for equitable market expansion.
Key Market Trends
Shift Toward Personalized and Preventive Healthcare
The market is witnessing a strong trend toward personalized and preventive care, with CMP testing playing an increasingly central role. Healthcare providers are leveraging CMP tests to proactively monitor patients for signs of metabolic imbalance, enabling tailored treatment strategies and early intervention.
This trend is supported by advancements in genomics, digital health tools, and AI-driven diagnostics that allow more nuanced interpretation of test results. Employers and insurance providers are also encouraging preventive health screenings through wellness initiatives, further normalizing CMP testing as part of routine healthcare. As healthcare delivery models evolve to prioritize value-based and predictive care, demand for comprehensive metabolic panel testing is set to grow substantially.
Key Market Players
Abbott Laboratories
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings Limited
Sonic Healthcare Limited
Unipath Specialty Laboratory Limited
SYNLAB International GmbH
ARUP Laboratories
Genoptix, Inc.
Nova Medical, Inc.
Mindray Medical International Limited
Report Scope:
In this report, the Global Comprehensive Metabolic Panel Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Comprehensive Metabolic Panel Testing Market, By Analytes:
K+
Na+
Cl-
CO2
Glucose
BUN
Creatinine
Ca++
Albumin
Total protein
ALP
ALT
AST
Total bilirubin
Comprehensive Metabolic Panel Testing Market, By Disease:
Kidney Disease
Liver Disease
Diabetes
Others
Comprehensive Metabolic Panel Testing Market, By End Use:
Laboratory
PoC
PoC (Instruments)
Comprehensive Metabolic Panel Testing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Comprehensive Metabolic Panel Testing Market.
Available Customizations:
Global Comprehensive Metabolic Panel Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Comprehensive Metabolic Panel Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Analytes (K+, Na+, Cl-, CO2, Glucose, BUN, Creatinine, Ca++, Albumin, Total protein, ALP, ALT, AST, Total bilirubin)
5.2.2. By Disease (Kidney Disease, Liver Disease, Diabetes, Others)
5.2.3. By End Use (Laboratory, PoC, PoC (Instruments))
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Comprehensive Metabolic Panel Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Analytes
6.2.2. By Disease
6.2.3. By End Use
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Comprehensive Metabolic Panel Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Analytes
6.3.1.2.2. By Disease
6.3.1.2.3. By End Use
6.3.2. Mexico Comprehensive Metabolic Panel Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Analytes
6.3.2.2.2. By Disease
6.3.2.2.3. By End Use
6.3.3. Canada Comprehensive Metabolic Panel Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Analytes
6.3.3.2.2. By Disease
6.3.3.2.3. By End Use
7. Europe Comprehensive Metabolic Panel Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Analytes
7.2.2. By Disease
7.2.3. By End Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Comprehensive Metabolic Panel Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Analytes
7.3.1.2.2. By Disease
7.3.1.2.3. By End Use
7.3.2. Germany Comprehensive Metabolic Panel Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Analytes
7.3.2.2.2. By Disease
7.3.2.2.3. By End Use
7.3.3. United Kingdom Comprehensive Metabolic Panel Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Analytes
7.3.3.2.2. By Disease
7.3.3.2.3. By End Use
7.3.4. Italy Comprehensive Metabolic Panel Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Analytes
7.3.4.2.2. By Disease
7.3.4.2.3. By End Use
7.3.5. Spain Comprehensive Metabolic Panel Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Analytes
7.3.5.2.2. By Disease
7.3.5.2.3. By End Use
8. Asia-Pacific Comprehensive Metabolic Panel Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Analytes
8.2.2. By Disease
8.2.3. By End Use
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Comprehensive Metabolic Panel Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Analytes
8.3.1.2.2. By Disease
8.3.1.2.3. By End Use
8.3.2. India Comprehensive Metabolic Panel Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Analytes
8.3.2.2.2. By Disease
8.3.2.2.3. By End Use
8.3.3. South Korea Comprehensive Metabolic Panel Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Analytes
8.3.3.2.2. By Disease
8.3.3.2.3. By End Use
8.3.4. Japan Comprehensive Metabolic Panel Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Analytes
8.3.4.2.2. By Disease
8.3.4.2.3. By End Use
8.3.5. Australia Comprehensive Metabolic Panel Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Analytes
8.3.5.2.2. By Disease
8.3.5.2.3. By End Use
9. South America Comprehensive Metabolic Panel Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Analytes
9.2.2. By Disease
9.2.3. By End Use
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Comprehensive Metabolic Panel Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Analytes
9.3.1.2.2. By Disease
9.3.1.2.3. By End Use
9.3.2. Argentina Comprehensive Metabolic Panel Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Analytes
9.3.2.2.2. By Disease
9.3.2.2.3. By End Use
9.3.3. Colombia Comprehensive Metabolic Panel Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Analytes
9.3.3.2.2. By Disease
9.3.3.2.3. By End Use
10. Middle East and Africa Comprehensive Metabolic Panel Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Analytes
10.2.2. By Disease
10.2.3. By End Use
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Comprehensive Metabolic Panel Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Analytes
10.3.1.2.2. By Disease
10.3.1.2.3. By End Use
10.3.2. Saudi Arabia Comprehensive Metabolic Panel Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Analytes
10.3.2.2.2. By Disease
10.3.2.2.3. By End Use
10.3.3. UAE Comprehensive Metabolic Panel Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Analytes
10.3.3.2.2. By Disease
10.3.3.2.3. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Quest Diagnostics Incorporated
14.3. Laboratory Corporation of America Holdings Limited
